Loading...

Home
ETF
QNTM

QNTM

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

QNTM News

Quantum BioPharma Announces New Marketing Partnership

18h agoNewsfilter

Quantum BioPharma Unveils Novel Drug for Multiple Sclerosis

Jun 26 2026Globenewswire

Quantum BioPharma Advances New MS Treatment Drug

Jun 25 2026Newsfilter

Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS

Jun 24 2026Globenewswire

Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS into Phase 2 Trials

Jun 24 2026Newsfilter

Quantum BioPharma Advances Novel MS Drug Candidate

Jun 23 2026Newsfilter

Quantum BioPharma Advances MS Drug into Phase 2 Trials

Jun 22 2026Globenewswire

Quantum BioPharma Advances New MS Drug Candidate Lucid-MS

Jun 22 2026Newsfilter

Quantinuum's IPO Performance and Market Impact

Jun 05 2026CNBC

Quantum BioPharma Faces Clinical Hold on Lucid-MS

Jun 01 2026Newsfilter

Quantum BioPharma Achieves Milestone in MGH Collaboration Study

May 18 2026Newsfilter

Quantum BioPharma Announces Marketing Partnerships for Investor Awareness

Apr 28 2026Newsfilter

Quantum BioPharma Appoints New CEO to Drive Market Expansion

Apr 22 2026Newsfilter

Quantum BioPharma Submits IND Application for Lucid-MS

Apr 01 2026Newsfilter

Quantum BioPharma Partners with Allucent for Phase 2 MS Trial

Mar 30 2026stocktwits

Quantum BioPharma Announces Stock Option Grant

Mar 27 2026Newsfilter